Clinical Performance of High Viscosity Bioactive Injectable Composite in Deep Marginal Elevation

Launched by FUTURE UNIVERSITY IN EGYPT · Mar 8, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new type of dental material called a high viscosity bioactive injectable composite. This material is being tested for its ability to improve dental health, particularly in deep cavities located below the gum line (called deep marginal elevation). The composite is designed to release helpful minerals like fluoride, which can strengthen teeth and make them more resistant to cavities. By using this advanced material, the goal is to achieve better dental restoration outcomes and support healthier gums.

To participate in this trial, individuals must be adults between the ages of 20 and 50 and have good oral hygiene. They should not have any dental issues like infections or heavy smoking habits, and they should not be undergoing orthodontic treatment. Participants will have the chance to help researchers understand how this new material can improve dental care. The trial is currently not recruiting participants, but it aims to gather valuable information that could lead to better treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adult Patient (20-50 years old)
• • 2. Good oral hygiene (plaque index 0 or 1)
• • 3. Patient approval
• • 4. Absence of parafunctional habits and/or bruxism
• • 5. No endodontic treatment
• • 6. No abscess
• • 7. No partial or fixed denture
• Exclusion Criteria:
• • 1. Patients with known allergic or adverse reaction to the tested materials.
• • 2. Bad oral hygiene
• • 3. Systematic disease that may affect participation.
• • 4. Xerostomic patients.
• • 5. Patients with active periodontal disease.
• • 6. Heavy smokers (those who smoke greater than or equal to 25 or more cigarettes a day)
• • 7. Orthodontic treatment patient